dc.contributor.author | Johansson, Hanna Katarina Lilith | |
dc.contributor.author | Svingen, Terje | |
dc.contributor.author | Boberg, Julie | |
dc.contributor.author | Fowler , Paul A | |
dc.contributor.author | Stead, David | |
dc.contributor.author | Vinggaard, Anne Marie | |
dc.contributor.author | Filis, Panagiotis | |
dc.date.accessioned | 2020-05-20T07:20:03Z | |
dc.date.available | 2020-05-20T07:20:03Z | |
dc.date.issued | 2020-04 | |
dc.identifier.citation | Johansson , H K L , Svingen , T , Boberg , J , Fowler , P A , Stead , D , Vinggaard , A M & Filis , P 2020 , ' Calretinin is a novel candidate marker for adverse ovarian effects of early life exposure to mixtures of endocrine disruptors in the rat ' , Archives of Toxicology , vol. 94 , pp. 1241-1250 . https://doi.org/10.1007/s00204-020-02697-3 | en |
dc.identifier.issn | 0340-5761 | |
dc.identifier.other | PURE: 158359947 | |
dc.identifier.other | PURE UUID: 26e94702-63f6-4365-b76f-84d1865ff501 | |
dc.identifier.other | PubMed: 32221642 | |
dc.identifier.other | WOS: 000521900800001 | |
dc.identifier.other | SCOPUS: 85082429722 | |
dc.identifier.other | Scopus: 85082429722 | |
dc.identifier.other | ORCID: /0000-0001-9268-5868/work/76974325 | |
dc.identifier.other | ORCID: /0000-0002-4831-9075/work/79059739 | |
dc.identifier.uri | https://hdl.handle.net/2164/14335 | |
dc.description | Open Access via Springer Compact Acknowledgements This work was funded by the Ministry of Environment and Food of Denmark, and by a grant from the European Commission 7th Framework Program CONTAMED (Contaminant mixtures and human reproductive health-novel strategies for health impact and risk assessment of endocrine disrupters, grant agreement no.: 215202), as well as the Medical Research Council (UK) (MR/L010011/1 to PAF) and the EU Horizon 2020 project FREIA (Grant Number 825100). We would like to thank Heidi Letting, the Animal facilities at DTU food, and the University of Aberdeen Proteomics Core Facility for their support and assistance in this work. | en |
dc.format.extent | 10 | |
dc.language.iso | eng | |
dc.relation.ispartof | Archives of Toxicology | en |
dc.rights | This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. | en |
dc.subject | ovary | en |
dc.subject | proteome | en |
dc.subject | endocrine disruptor | en |
dc.subject | calretinin | en |
dc.subject | Ovarian Dysgenesis Syndrome | en |
dc.subject | AOP | en |
dc.subject | Calretinin | en |
dc.subject | Ovarian dysgenesis syndrome | en |
dc.subject | Endocrine disruption | en |
dc.subject | Proteome | en |
dc.subject | FEMALE | en |
dc.subject | Ovary | en |
dc.subject | CHEMICALS | en |
dc.subject | INTRAUTERINE | en |
dc.subject | OUTCOME PATHWAYS | en |
dc.subject | MENOPAUSE | en |
dc.subject | EXPRESSION | en |
dc.subject | PROTEOMICS | en |
dc.subject | AGE | en |
dc.subject | R Medicine | en |
dc.subject | Health, Toxicology and Mutagenesis | en |
dc.subject | Toxicology | en |
dc.subject | Medical Research Council (MRC) | en |
dc.subject | MR/L010011/1 | en |
dc.subject | European Commission | en |
dc.subject | 215202 | en |
dc.subject | 825100 | en |
dc.subject | Supplementary data available | en |
dc.subject.lcc | R | en |
dc.title | Calretinin is a novel candidate marker for adverse ovarian effects of early life exposure to mixtures of endocrine disruptors in the rat | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.contributor.institution | University of Aberdeen.Biological Sciences (Research Theme) | en |
dc.contributor.institution | University of Aberdeen.Clinical Medicine | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.1007/s00204-020-02697-3 | |
dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85082429722&partnerID=8YFLogxK | en |